GRIP-Studie
Projektleiter:
Finanzierung:
Industrie;
Prospective non-randomized (pharmacoepidemiologic) cohort study (open-label, multicenter) to assess the magnitude of potential risk with the administration of Gadovist in patients with moderate to severe renal impairment for the development of nephrogenic systemic fibrosis (NSF) based on diagnostically specific clinical and histopathologic information
Schlagworte
NSF
Kontakt
Prof. Dr. Jens Ricke
Otto-von-Guericke-Universität Magdeburg
Universitätsklinik für Radiologie und Nuklearmedizin
Leipziger Straße 44
39120
Magdeburg
Tel.:+49 391 6713030
weitere Projekte
Die Daten werden geladen ...